Contact
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients
TO:
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients
TO: